The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
Open accessAbstract
Background & Aims: In 2015, a national Egyptian health issue survey was conducted to describe the prevalence of hepatitis C virus (HCV) infection. In this paper, we describe the HCV burden in 2015, compare the results with the national survey conducted in 2008, and discuss the implications of the new findings on prevention of HCV in Egypt. Methods: A multistage probability sampling approach was used, similar to the national demographic survey conducted in 2008. More than 90% of sampled individuals complied with the interview and provided blood samples. Results: In the 15–59‐year age groups, the prevalence of HCV antibody was found to be 10.0% (95% CI 9.5–10.5) and that of HCV RNA to be 7.0% (95% CI 6.6–7.4). In children, 1–14 years old, the prevalence of HCV antibody and HCV RNA were 0.4% (95% CI 0.3–0.5) and 0.2% (95% CI 0.1–0.3) respectively. Approximately, 3.7 million persons have chronic HCV infection in the age group 15–59 in 2015. An estimated 29% reduction in HCV RNA prevalence has been seen since 2008, which is largely attributable to the ageing of the group infected 40–50 years ago during the mass schistosomiasis treatment campaigns. Prevention efforts may have also contributed to this decline, with an estimated 75% (95% CI 6–45) decrease in HCV incidence in the 0–19 year age groups over the past 20 years. Conclusions: These findings can be used to shape future HCV prevention policies in Egypt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sontrop, J. M., Dixon, S. N., Garg, A. X., Buendia-Jimenez, I., Dohein, O., Huang, S.-H. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,871
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
Confidence intervals rather than P values: estimation rather than hypothesis testing.
Gardner, M. J., & Altman, D. G. (1986) · BMJ · doi:10.1136/bmj.292.6522.746 · Cited by 2,010
Global epidemiology and genotype distribution of the hepatitis C virus infection
Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.027 · Cited by 1,903
Interval estimation for the difference between independent proportions: comparison of eleven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<873::aid-sim779>3.0.co;2-i · Cited by 1,851
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Statistical Methods in Medical Research
Lachenbruch, P. A. (1972) · Technometrics · doi:10.1080/00401706.1972.10488903 · Cited by 1,703
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06527-7 · Cited by 1,131
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Hepatitis C Virus Infection in A Community in the Nile Delta: Risk Factors for Seropositivity
Habib, M., Mohamed, M. K., Abdel-Aziz, F., Magder, L. S., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Anwar, W., Strickland, T. G., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.20797 · Cited by 295
Abdel-Aziz, F., Habib, M., Mohamed, M. K., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N. N., Thomas, D., Fix, A. D., Strickland, T. G., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.8438 · Cited by 265
Hepatitis c in a community in Upper Egypt: risk factors for infection.
Medhat, A., Shehata, M., Magder, L. S., Mikhail, N., Abdel-Baki, L., Nafeh, M., Abdel-Hamid, M., Strickland, G. T., & Fix, A. D. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.66.633 · Cited by 168
Ruane, P. J., Ain, D., Stryker, R., Meshrekey, R., Soliman, M., Wolfe, P. R., Riad, J., Mikhail, S., Kersey, K., Jiang, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.044 · Cited by 167
The current and future disease burden of chronic hepatitis C virus infection in Egypt
Waked, I. A., Doss, W., El-Sayed, M. H., Estes, C. R., Razavi, H. A., Shiha, G. E.-S., Yosry, A., & Esmat, G. (2014) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2014.04.003 · Cited by 129
Epidemiology of hepatitis C in Europe
Negro, F. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.023 · Cited by 104
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS
Ford, N. P., Singh, K. P., Cooke, G., Mills, E. J., von Schoen-Angerer, T., Kamarulzaman, A., & du Cros, P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis227 · Cited by 102
High prevalence of hepatitis C virus among urban and rural population groups in Egypt
Gohary, A. E., Hassan, A., Nooman, Z. M., Lavanchy, D., Mayerat, C., Ayat, A., Fawaz, N., Gobran, F., Ahmed, M. A. B. H. A., Kawano, F., et al. (1995) · Acta Tropica · doi:10.1016/0001-706x(95)00075-p · Cited by 83
Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women
Stoszek, S., Abdel‐Hamid, M., Narooz, S., El-Daly, M. M., Saleh, D. A., Mikhail, N. N. H., Kassem, E., Hawash, Y. A., El-Kafrawy, S. A., Said, A., et al. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.05.021 · Cited by 76
Towards realistic estimates of HCV incidence in E gypt
Breban, R., Doss, W. H., Esmat, G., El-Sayed, M. H., Hellard, M. E., Ayscue, P., Albert, M. L., Fontanet, A. L., & Mohamed, M. K. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01650.x · Cited by 60
Self-citationObach, D., Deuffic‐Burban, S., Esmat, G., Anwar, W. A., Dewedar, S. A., Canva, V., Cousien, A., Doss, W. H., Mostafa, A., Pol, S., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu066 · Cited by 49
Self-citationBreban, R., Arafa, N., Leroy, S., Mostafa, A., Bakr, I., Tondeur, L., Abdel‐Hamid, M., Doss, W. H., Esmat, G., Mohamed, M. K., et al. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70188-3 · Cited by 42
Self-citationRisk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children
Esmat, G., Hashem, M. B., El‐Raziky, M. S., Elakel, W., El‐Naghy, S., El-Koofy, N. M., El‐Sayed, R., Ahmed, R. M., Attaallah, M., Hamid, M. A., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02643.x · Cited by 31
Obach, D., Yazdanpanah, Y., Esmat, G., Avihingsanon, A., Dewedar, S. A., Durier, N., ATTIA, A. K., Anwar, W. A., Cousien, A., Tangkijvanich, P., et al. (2015) · Hepatology · doi:10.1002/hep.27691 · Cited by 27
Self-citation
Cited by
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
Rashed, W. M., Kandeil, M. A. M., Mahmoud, M. O., & Ezzat, S. (2020) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-020-0016-x · Cited by 283
Management of Acute Mesenteric Venous Thrombosis: A Systematic Review of Contemporary Studies
Acosta, S., & Salim, S. (2021) · Scandinavian Journal of Surgery · doi:10.1177/1457496920969084 · Cited by 66
Metadata
- Authors
- Kandeel, A., Genedy, M., El‐Refai, S., Funk, A. L., Fontanet, A., & Talaat, M.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2016-06-30
- Volume
- 37
- Issue
- 1
- Pages
- 45-53
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2410976255
- Cited by
- 283
- References
- 24
- FWCI
- 27.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.